These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22706528)

  • 21. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
    Koczwara B; Spangenthal E; Bernstein SH
    Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of one hairy cell leukemia case with single course of cladribine].
    Zhang LJ; Qiu HX; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):336. PubMed ID: 21729604
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary T-lymphoblastic leukemia in a patient with hairy cell leukemia following cladribine therapy: report of an extremely rare case and review of the literature.
    Setoodeh R; Zhang L
    Leuk Lymphoma; 2012 Apr; 53(4):736-8. PubMed ID: 21980957
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hairy cell leukemia-variant with cladribine.
    Tetreault SA; Robbins BA; Saven A
    Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine].
    Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S
    Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-chlorodeoxyadenosine-associated transient acantholytic dermatosis in hairy cell leukemia patients.
    Cohen PR; Kurzrock R
    Am J Dermatopathol; 1999 Feb; 21(1):106-8. PubMed ID: 10027536
    [No Abstract]   [Full Text] [Related]  

  • 28. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of toxicity in a cladribine extravasation.
    Mateu-de Antonio J; Acuña-Reina L; Pons JC; Buisán MJ
    Ann Pharmacother; 1999; 33(7-8):873. PubMed ID: 10466922
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful induction of long-term remission using rituximab in a patient with refractory hairy cell leukemia-Japanese variant.
    Imamura T; Ohtsuka E; Ogata M; Oka F; Kashima K; Kikuchi H; Nasu M
    Int J Hematol; 2004 Dec; 80(5):432-4. PubMed ID: 15646655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol.
    Espinosa Lara P; Quirós Redondo V; Aguado Lobo M; Jiménez-Reyes J
    Ann Hematol; 2017 Jul; 96(7):1209-1210. PubMed ID: 28391438
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.
    Hoffman MA; Janson D; Rose E; Rai KR
    J Clin Oncol; 1997 Mar; 15(3):1138-42. PubMed ID: 9060556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairy cell leukaemia with advanced treatment - a case report.
    Momen A; Sarker CB; Siddiqui NI; Huq MH; Jamal MF; Talukder SI; Rahman KM
    Mymensingh Med J; 2003 Jul; 12(2):134-7. PubMed ID: 12894049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration].
    Terao T; Yuda J; Yamauchi N; Miyamoto K; Minami M; Kojima M; Sugano M; Kuwata T; Minami Y
    Rinsho Ketsueki; 2019; 60(6):559-564. PubMed ID: 31281144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
    Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA
    J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus positive large B-cell lymphoma arising in a patient previously treated with Cladribine for hairy cell leukemia.
    Bhargava R; Barbashina V; Filippa DA; Teruya-Feldstein J
    Leuk Lymphoma; 2004 May; 45(5):1043-8. PubMed ID: 15291365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.
    Forconi F; Toraldo F; Sozzi E; Amato T; Raspadori D; Lauria F
    Leuk Lymphoma; 2007 Dec; 48(12):2441-3. PubMed ID: 18067021
    [No Abstract]   [Full Text] [Related]  

  • 39. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy.
    Hacioglu S; Bilen Y; Eser A; Sivgin S; Gurkan E; Yildirim R; Aydogdu I; Dogu MH; Yilmaz M; Kayikci O; Tombak A; Kuku I; Celebi H; Akay MO; Esen R; Korkmaz S; Keskin A
    Hematol Oncol; 2015 Dec; 33(4):192-8. PubMed ID: 25393847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hairy Cell Leukemia and cutaneous involvement.
    Ergene U; Ozbalcı D; Işisağ A
    Transfus Apher Sci; 2012 Apr; 46(2):231-2. PubMed ID: 22370038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.